Gallacher Capital Management LLC Has $504,000 Stake in HCA Healthcare, Inc. (NYSE:HCA)

Gallacher Capital Management LLC grew its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 4.9% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 1,679 shares of the company’s stock after acquiring an additional 79 shares during the quarter. Gallacher Capital Management LLC’s holdings in HCA Healthcare were worth $504,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of HCA. Assetmark Inc. increased its holdings in HCA Healthcare by 5.5% in the 3rd quarter. Assetmark Inc. now owns 1,834 shares of the company’s stock valued at $746,000 after buying an additional 96 shares during the period. GSA Capital Partners LLP bought a new position in HCA Healthcare in the third quarter valued at approximately $567,000. CIBC Asset Management Inc increased its stake in shares of HCA Healthcare by 4.9% in the 3rd quarter. CIBC Asset Management Inc now owns 29,427 shares of the company’s stock valued at $11,960,000 after purchasing an additional 1,362 shares during the last quarter. Empowered Funds LLC increased its stake in shares of HCA Healthcare by 10.2% in the 3rd quarter. Empowered Funds LLC now owns 21,824 shares of the company’s stock valued at $8,870,000 after purchasing an additional 2,019 shares during the last quarter. Finally, Valley Wealth Managers Inc. grew its position in HCA Healthcare by 14.4% in the third quarter. Valley Wealth Managers Inc. now owns 1,383 shares of the company’s stock valued at $562,000 after acquiring an additional 174 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the stock. Bank of America decreased their price target on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, January 27th. KeyCorp decreased their target price on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 7th. Truist Financial reduced their price objective on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. JPMorgan Chase & Co. restated a “neutral” rating and set a $380.00 price target on shares of HCA Healthcare in a report on Tuesday, December 17th. Finally, Raymond James lowered shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. One analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $385.67.

HCA Healthcare Stock Up 1.6 %

Shares of HCA Healthcare stock opened at $319.82 on Friday. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. The stock’s 50-day moving average is $319.00 and its 200 day moving average is $345.26. The firm has a market cap of $78.74 billion, a price-to-earnings ratio of 14.56, a PEG ratio of 1.10 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter last year, the firm earned $5.90 EPS. Equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be issued a $0.72 dividend. The ex-dividend date of this dividend is Monday, March 17th. This represents a $2.88 annualized dividend and a yield of 0.90%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio is presently 13.11%.

Insiders Place Their Bets

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the firm’s stock in a transaction on Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 1.60% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.